NCT01179347View on ClinicalTrials.gov

Tiotropium Bromide in Cystic Fibrosis

PHASE3CompletedINTERVENTIONAL
Enrollment

464

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

March 31, 2012

Conditions
Cystic Fibrosis
Interventions
DRUG

tiotropium Respimat® inhaler

to evaluate safety and efficacy tiotropium delivered with Respimat® inhaler compared to placebo.

DRUG

Placebo Respimat® inhaler

patient to receive placebo matching active drug once daily

Trial Locations (99)

Unknown

205.438.01004 Boehringer Ingelheim Investigational Site, Tuscon

205.438.01011 Boehringer Ingelheim Investigational Site, San Diego

205.438.01018 Boehringer Ingelheim Investigational Site, Jacksonville

205.438.01008 Boehringer Ingelheim Investigational Site, Orlando

205.438.01014 Boehringer Ingelheim Investigational Site, Orlando

205.438.01021 Boehringer Ingelheim Investigational Site, Orlando

205.438.01007 Boehringer Ingelheim Investigational Site, Indianapolis

205.438.01006 Boehringer Ingelheim Investigational Site, South Bend

205.438.01001 Boehringer Ingelheim Investigational Site, Detroit

205.438.01010 Boehringer Ingelheim Investigational Site, Manchester

205.438.01003 Boehringer Ingelheim Investigational Site, Syracuse

205.438.01019 Boehringer Ingelheim Investigational Site, Cleveland

205.438.01013 Boehringer Ingelheim Investigational Site, Oklahoma City

205.438.01005 Boehringer Ingelheim Investigational Site, Charleston

205.438.01012 Boehringer Ingelheim Investigational Site, Milwaukee

205.438.61003 Boehringer Ingelheim Investigational Site, Chermside

205.438.61004 Boehringer Ingelheim Investigational Site, Herston

205.438.61001 Boehringer Ingelheim Investigational Site, Adelaide

205.438.61002 Boehringer Ingelheim Investigational Site, Subiaco

205.438.43001 Boehringer Ingelheim Investigational Site, Innsbruck

205.438.43002 Boehringer Ingelheim Investigational Site, Salzburg

205.438.32002 Boehringer Ingelheim Investigational Site, Brussels

205.438.32004 Boehringer Ingelheim Investigational Site, Edegem

205.438.32003 Boehringer Ingelheim Investigational Site, Jette

205.438.32001 Boehringer Ingelheim Investigational Site, Leuven

205.438.02005 Boehringer Ingelheim Investigational Site, Calgary

205.438.02007 Boehringer Ingelheim Investigational Site, Vancouver

205.438.02004 Boehringer Ingelheim Investigational Site, Halifax

205.438.02003 Boehringer Ingelheim Investigational Site, Hamilton

205.438.02006 Boehringer Ingelheim Investigational Site, Toronto

205.438.02001 Boehringer Ingelheim Investigational Site, Sherbrooke

205.438.42002 Boehringer Ingelheim Investigational Site, Brno

205.438.42003 Boehringer Ingelheim Investigational Site, Brno

205.438.42004 Boehringer Ingelheim Investigational Site, Olomouc

205.438.42001 Boehringer Ingelheim Investigational Site, Prague

205.438.33010 Boehringer Ingelheim Investigational Site, Angers

205.438.33013 Boehringer Ingelheim Investigational Site, Bron

205.438.33002 Boehringer Ingelheim Investigational Site, Lille

205.438.33015 Boehringer Ingelheim Investigational Site, Lisieux

205.438.33003 Boehringer Ingelheim Investigational Site, Montpellier

205.438.33005 Boehringer Ingelheim Investigational Site, Nantes

205.438.33014 Boehringer Ingelheim Investigational Site, Nice

205.438.33001 Boehringer Ingelheim Investigational Site, Paris

205.438.33006 Boehringer Ingelheim Investigational Site, Paris

205.438.33007 Boehringer Ingelheim Investigational Site, Paris

205.438.33011 Boehringer Ingelheim Investigational Site, Rennes

205.438.33008 Boehringer Ingelheim Investigational Site, Roscoff

205.438.33004 Boehringer Ingelheim Investigational Site, Rouen

205.438.33009 Boehringer Ingelheim Investigational Site, Vannes

205.438.49001 Boehringer Ingelheim Investigational Site, Bochum

205.438.49002 Boehringer Ingelheim Investigational Site, Frankfurt

205.438.49012 Boehringer Ingelheim Investigational Site, Frankfurt

205.438.49011 Boehringer Ingelheim Investigational Site, Frankfurt am Main

205.438.49006 Boehringer Ingelheim Investigational Site, Gerlingen

205.438.49007 Boehringer Ingelheim Investigational Site, Giessen

205.438.49005 Boehringer Ingelheim Investigational Site, Hamburg

205.438.49003 Boehringer Ingelheim Investigational Site, München

205.438.49008 Boehringer Ingelheim Investigational Site, Tübingen

205.438.36002 Boehringer Ingelheim Investigational Site, Budapest

205.438.36003 Boehringer Ingelheim Investigational Site, Mosdós

205.438.36004 Boehringer Ingelheim Investigational Site, Szeged

205.438.35301 Boehringer Ingelheim Investigational Site, Dublin

205.438.97003 Boehringer Ingelheim Investigational Site, Haifa

205.438.97001 Boehringer Ingelheim Investigational Site, Jerusalem

205.438.97002 Boehringer Ingelheim Investigational Site, Petah Tikva

205.438.97004 Boehringer Ingelheim Investigational Site, Tel Litwinsky

205.438.39001 Boehringer Ingelheim Investigational Site, Florence

205.438.39003 Boehringer Ingelheim Investigational Site, Genova

205.438.39002 Boehringer Ingelheim Investigational Site, Verona

205.438.48001 Boehringer Ingelheim Investigational Site, Lodz

205.438.48002 Boehringer Ingelheim Investigational Site, Rabka-Zdrój

205.438.48003 Boehringer Ingelheim Investigational Site, Warsaw

205.438.35001 Boehringer Ingelheim Investigational Site, Lisbon

205.438.35002 Boehringer Ingelheim Investigational Site, Lisbon

205.438.35003 Boehringer Ingelheim Investigational Site, Porto

205.438.35004 Boehringer Ingelheim Investigational Site, Porto

205.438.07001 Boehringer Ingelheim Investigational Site, Moscow

205.438.07005 Boehringer Ingelheim Investigational Site, Moscow

205.438.07003 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.438.07004 Boehringer Ingelheim Investigational Site, Voronezh

205.438.07002 Boehringer Ingelheim Investigational Site, Yaroslavl

205.438.42102 Boehringer Ingelheim Investigational Site, Banská Bystrica

205.438.42101 Boehringer Ingelheim Investigational Site, Bratislava

205.438.42103 Boehringer Ingelheim Investigational Site, Košice

205.438.27001 Boehringer Ingelheim Investigational Site, Cape Town

205.438.34005 Boehringer Ingelheim Investigational Site, Barcelona

205.438.34001 Boehringer Ingelheim Investigational Site, Madrid

205.438.34002 Boehringer Ingelheim Investigational Site, Madrid

205.438.34004 Boehringer Ingelheim Investigational Site, Valencia

205.438.41003 Boehringer Ingelheim Investigational Site, Basel

205.438.41004 Boehringer Ingelheim Investigational Site, Bern

205.438.41001 Boehringer Ingelheim Investigational Site, Zurich

205.438.41002 Boehringer Ingelheim Investigational Site, Zurich

205.438.44009 Boehringer Ingelheim Investigational Site, Brighton

205.438.44007 Boehringer Ingelheim Investigational Site, Cambridge

205.438.44004 Boehringer Ingelheim Investigational Site, Leeds

205.438.44005 Boehringer Ingelheim Investigational Site, Nottingham

205.438.44002 Boehringer Ingelheim Investigational Site, Plymouth

205.438.44003 Boehringer Ingelheim Investigational Site, Sheffield

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY